YM598 in Patients With Rising PSA After Initial Therapy for Localized Prostate Cancer

A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy

NCT00257478 ·Status: COMPLETED ·Phase: PHASE2

An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer Participants

NCT02294461 ·Status: COMPLETED ·Phase: PHASE3

Safety Study of Continued Enzalutamide Treatment In Prostate Cancer Patients

NCT01995513 ·Status: COMPLETED ·Phase: PHASE4

A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer

NCT06990880 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Analyze the Predictive Value of Gene TMPRSS2-ETS in Response to Enzalutamide in Patients With Prostate Cancer

NCT02288936 ·Status: COMPLETED ·Phase: PHASE2

Testing the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate Gland

NCT04530552 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

European Observational Study of Enzalutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)

NCT02495974 ·Status: COMPLETED

A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

NCT02960022 ·Status: RECRUITING ·Phase: PHASE2

Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone Therapy

NCT00148772 ·Status: COMPLETED ·Phase: PHASE2

Enzalutamide & Dutasteride/Finasteride as 1st Line Treatment for Patients =/> 65 Years Old With Prostate Cancer.

NCT02213107 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer

NCT01664923 ·Status: COMPLETED ·Phase: PHASE2

Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy

NCT02099864 ·Status: COMPLETED ·Phase: PHASE2

Study of Enzalutamide With and Without Sorafenib in Advanced Hepatocellular Carcinoma Patients

NCT02642913 ·Status: COMPLETED ·Phase: PHASE1

Study of ATN-224 in Patients With Prostate Cancer

NCT00405574 ·Status: UNKNOWN ·Phase: PHASE2

A Study of Single-Agent AT-101 in Men With Hormone Refractory Prostate Cancer

NCT00286806 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Determine Enzalutamide Long-term Safety and Efficacy After Anti-androgen Therapy for CRPC

NCT02669147 ·Status: COMPLETED

Enzalutamide for Bladder Cancer Chemoprevention

NCT02605863 ·Status: TERMINATED ·Phase: PHASE2

Phase II Study of Dasatinib (BMS-354825) for Androgen-deprived Progressive Prostate Cancer

NCT00385580 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure

NCT00038662 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Tolerability of Low-Dose Enzalutamide in Prostate Cancer

NCT06718647 ·Status: NOT_YET_RECRUITING

Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer

NCT01251861 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer

NCT00014586 ·Status: TERMINATED ·Phase: PHASE3

A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer

NCT01212991 ·Status: COMPLETED ·Phase: PHASE3

A Non-Interventional Study to Evaluate Time to Event and Healthcare Resource Utilisation for Prostate Cancer Participants Throughout the Disease Trajectories Until Progression or Death

NCT03619980 ·Status: COMPLETED

Study of Recurrent Prostate Cancer With Rising Prostate Specific Antigen (PSA)

NCT01118741 ·Status: COMPLETED ·Phase: NA